Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Ambio ; 43(1): 60-8, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24414805

RESUMEN

Integrated sediment multiproxy studies and modeling were used to reconstruct past changes in the Baltic Sea ecosystem. Results of natural changes over the past 6000 years in the Baltic Sea ecosystem suggest that forecasted climate warming might enhance environmental problems of the Baltic Sea. Integrated modeling and sediment proxy studies reveal increased sea surface temperatures and expanded seafloor anoxia (in deep basins) during earlier natural warm climate phases, such as the Medieval Climate Anomaly. Under future IPCC scenarios of global warming, there is likely no improvement of bottom water conditions in the Baltic Sea. Thus, the measures already designed to produce a healthier Baltic Sea are insufficient in the long term. The interactions between climate change and anthropogenic impacts on the Baltic Sea should be considered in management, implementation of policy strategies in the Baltic Sea environmental issues, and adaptation to future climate change.


Asunto(s)
Cambio Climático , Ecosistema , Países Bálticos , Sedimentos Geológicos , Océanos y Mares
2.
Neuron ; 48(2): 253-65, 2005 Oct 20.
Artículo en Inglés | MEDLINE | ID: mdl-16242406

RESUMEN

Precursor cells of the embryonic cortex sequentially generate neurons and then glial cells, but the mechanisms regulating this neurogenic-to-gliogenic transition are unclear. Using cortical precursor cultures, which temporally mimic this in vivo differentiation pattern, we demonstrate that cortical neurons synthesize and secrete the neurotrophic cytokine cardiotrophin-1, which activates the gp130-JAK-STAT pathway and is essential for the timed genesis of astrocytes in vitro. Our data indicate that a similar phenomenon also occurs in vivo. In utero electroporation of neurotrophic cytokines in the environment of embryonic cortical precursors causes premature gliogenesis, while acute perturbation of gp130 in cortical precursors delays the normal timed appearance of astrocytes. Moreover, the neonatal cardiotrophin-1-/- cortex contains fewer astrocytes. Together, these results describe a neural feedback mechanism; newly born neurons produce cardiotrophin-1, which instructs multipotent cortical precursors to generate astrocytes, thereby ensuring that gliogenesis does not occur until neurogenesis is largely complete.


Asunto(s)
Diferenciación Celular/fisiología , Corteza Cerebral/citología , Citocinas/fisiología , Neuroglía/fisiología , Neuronas/fisiología , Células Madre , Análisis de Varianza , Animales , Western Blotting/métodos , Recuento de Células/métodos , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Corteza Cerebral/embriología , Factor Neurotrófico Ciliar/farmacología , Contactinas , Medios de Cultivo Condicionados/farmacología , Quinasa 2 Dependiente de la Ciclina/metabolismo , Citocinas/deficiencia , Citocinas/farmacología , Interacciones Farmacológicas , Proteínas ELAV/metabolismo , Embrión de Mamíferos , Activación Enzimática/fisiología , Inhibidores Enzimáticos/farmacología , Flavonoides/farmacología , Técnica del Anticuerpo Fluorescente/métodos , Proteína Ácida Fibrilar de la Glía/metabolismo , Proteínas Fluorescentes Verdes/metabolismo , Receptores de Hialuranos/metabolismo , Interleucina-6/farmacología , Proteínas de Filamentos Intermediarios/metabolismo , Factor Inhibidor de Leucemia , Ratones , Ratones Transgénicos , Factores de Crecimiento Nervioso/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Nestina , Moléculas de Adhesión de Célula Nerviosa/metabolismo , Proteínas de Neurofilamentos/metabolismo , Organogénesis , Fosfopiruvato Hidratasa/metabolismo , Proteínas Tirosina Quinasas/metabolismo , ARN Mensajero/biosíntesis , ARN Interferente Pequeño/farmacología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Subunidad beta de la Proteína de Unión al Calcio S100 , Proteínas S100/metabolismo , Factores de Transcripción STAT/metabolismo , Células Madre/efectos de los fármacos , Factores de Tiempo , Transfección/métodos , Tubulina (Proteína)/metabolismo , Tirfostinos/farmacología
3.
Thromb Haemost ; 92(6): 1201-6, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15583724

RESUMEN

Clopidogrel is an effective and specific inhibitor of ADP-induced platelet aggregation. After metabolic activation, the active clopidogrel metabolite irreversibly impairs the human platelet P2Y12 ADP receptor. Gialpha-protein activation and inhibition of vasodilator-stimulated phosphoprotein (VASP) phosphorylation are two key elements of the P2Y12 receptor pathway suitable for quantitation of clopidogrel effects. So far, only limited data exist about a diminished responsiveness to clopidogrel and underlying possible mechanisms. We investigated clopidogrel effects in 57 patients after percutaneous coronary intervention and stent implantation by flow cytometry for the analysis of intracellular VASP phosphorylation. Patients were treated with a 300 mg clopidogrel loading dose, followed by 75 mg/day clopidogrel in combination with 100 mg/day aspirin. Samples were drawn after a median of 5 days of clopidogrel treatment. Considerable differences in the responsiveness to clopidogrel could be observed and it was shown that 17.5% (10/57) of the patients revealed an inadequate responsiveness to clopidogrel despite continuation of clopidogrel intake. Comparable amounts of Gialpha and VASP were found in two clopidogrel low-responding patients as well as in two responding patients. To exclude a molecular defect of P2Y12 ADP receptor, the P2Y12 receptor gene of eight clopidogrel treated patients (seven patients with inadequate responsiveness, one responder) was sequenced. We only found a single silent mutation in exon 2 at position 1828 (GA). We suggest that individual differences in clopidogrel metabolization could cause relevant variations in clopidogrel responsiveness despite the use of a 300 mg clopidogrel loading dose.


Asunto(s)
Angina de Pecho/terapia , Cardiopatías/terapia , Inhibidores de Agregación Plaquetaria/farmacología , Ticlopidina/análogos & derivados , Ticlopidina/farmacología , Adenosina Difosfato/química , Adenosina Difosfato/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Angioplastia Coronaria con Balón/métodos , Aspirina/farmacología , Moléculas de Adhesión Celular/metabolismo , Clopidogrel , Quimioterapia Combinada , Femenino , Citometría de Flujo , Subunidades alfa de la Proteína de Unión al GTP Gi-Go/metabolismo , Cardiopatías/tratamiento farmacológico , Humanos , Masculino , Proteínas de la Membrana/antagonistas & inhibidores , Proteínas de Microfilamentos , Persona de Mediana Edad , Fosfoproteínas/metabolismo , Fosforilación , Activación Plaquetaria , Pruebas de Función Plaquetaria , Estudios Prospectivos , Antagonistas del Receptor Purinérgico P2 , Receptores Purinérgicos P2Y12 , Stents , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA